Who owns Intellia Therapeutics?
Intellia Therapeutics
- Brand origin
- United States
- Main production
- United States
A genome editing company focused on the development of proprietary, potentially curative therapeutics using CRISPR/Cas9 technology.
Is the information about Intellia Therapeutics correct?
Updated: 26 August 2026 ·
Ownership data is compiled from public sources and verified where possible. Spotted an error? Suggest a correction below.
